Postural effects on peritoneal transport and systemic uptake of radiolabeled monoclonal antibodies

Cancer Immunology Immunotherapy

Volumn 44, Issue 3, 1997, Pages 173-178

  Barrett, Jeffrey S ^a   Fisher, Susan J ^b   Wahl, Richard L ^b  

^a DUPONT COMPANY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Intraperitoneal; Monoclonal antibodies; Pharmacokinetics; Posture

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; IODINE 125; IODINE 131; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; BODY POSTURE; DIAPHRAGM; DRUG ABSORPTION; FEMALE; HALF LIFE TIME; HYDROSTATIC PRESSURE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; PERITONEUM; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RAT; STEADY STATE; SUPINE POSITION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; INJECTIONS, INTRAPERITONEAL; MICE; NEOPLASMS, EXPERIMENTAL; RADIOIMMUNOTHERAPY; RATS; TISSUE DISTRIBUTION;

EID: 0030979866     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050370     Document Type: Article

References (28)

1. Reilly RM, Sandhu J, Alvarez-Diez TM, Gallinger S, Kirsh J, Stern H (1995) Problems of delivery of monoclonal antibodies: pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet 28: 126-142
2. Dedrick RL, Myers CE, Bungay PM, DeVita VT (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62: 1-11
3. Jones RB, Collins JM, Myers CG, et al (1981) High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Res 41: 55-59
4. Speyer JL, Collins JM, Dedrick RL, et al (1980) Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 40: 567-572
5. Muto MG, Finkler NJ, Kassis AI, Howes AE, Anderson LL, Lau CC, Zurawski VR, Weadock K, Tumeh SS, Lavin P, Knapp RC (1992) Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125. Gynecol Oncol 45: 265-272
6. Buckman R, De Angelis C, Shaw P, Covens A, Osborne R, Kerr I, Reed R, Michaels H, Woo M, Reilly R, Law J, Baumal R, Groves E, Marks A (1992) Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3. Gynecol Oncol 47: 102-109
7. Rubin SC, Kostakoglu L, Divgi C, Federici MG, Finstad CL, Lloyd KO, Larson SM, Hoskins WJ (1993) Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX 35 in patients with epithelial ovarian cancer. Gynecol Oncol 51: 61-66
8. Wahl RL, Barrett JS, Geatti O, Wilson B, Liebert M, Wagner JG (1988) Intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage. Cancer Immunol Immunother 26: 187-201
9. Barrett JS, Wahl RL, Wagner JG, Brown R, Fisher SJ (1990) Investigations into the route of uptake and pharmacokinetics of intraperitoneally administered monoclonal antibodies I. Transdiaphragmatic blockade of the terminal lymphatics in the rat. Cancer Immunol Immunother 31: 365-372
10. Feldman GB, Knapp RC (1974) Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol 119: 991-994
11. Barrett JS, Wahl RL, Wagner JG, Fisher SJ (1991) Investigations into the route of uptake and pharmacokinetics of intraperitoneally administered monoclonal antibodies II. The effect of protein dose and volume of IP injection in the rat. J Cancer Res 51: 3434-3444
12. Olin T, Saldeen T (1964) The lymphatic pathways from the peritoneal cavity: a lymphangiographic study in the rat. Cancer Res 24: 1700-1711
13. Tsilibary EC and Wissig SL (1987) Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents. Am J Anat 180: 195-207
14. Courtice FC, Steinbeck AW (1950) The lymphatic drainage of plasma from the peritoneal cavity of the cat. Aust J Exp Biol Med Sci 28: 161-169
15. Higgins GM, Graham AS (1929) Lymphatic drainage from the peritoneal cavity in the dog. Arch Surg 19: 453-465
16. Feldman GB, Knapp RC, Order SE, Hellman S (1972) The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res 32: 1663-1666
17. Abernethy NJ, Chin W, Hay JB, Rodela H, Oreopoulos D, Johnston MG (1981) Lymphatic drainage of the peritoneal cavity in the sheep. Am J Physiol 260: F353-F358
18. Fowler GR (1900) Diffuse septic peritonitis, with special reference to a new method of treatment, namely the elevated head and trunk posture, to facilitate drainage into the pelvis, with a report of nine consecutive cases of recovery. Med Rec 57: 617-623
19. Courtice FC, Steinbeck AW (1951) The effects of lymphatic obstruction and of posture on the absorption of protein from the peritoneal cavity. Aust J Exp Biol Med Sci 29: 451-458
20. Wahl RL, Liebert M, Biesman B, Roberts J, Jackson G, Kronberg S, Laino L (1986) Production and characterization of a murine monoclonal antibody reactive with ovarian and other epithelial carcinomas. Proc Am Assoc Cancer Res 27: 355
21. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685
22. Markwell MAK (1982) A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem 125: 427-432
23. Wahl RL, Liebert M, Carey JR, Jackson G (1985) Quality control of radiolabeled monoclonal antibodies: immunological and radiochemical. Cancer Drug Delivery 2: 236
24. Wahl RL, Gyves J, Gross BH, Cochran M, Juni JE, Arnstein NB, Luhti D, Ackermann RJ (1989) SPECT of the peritoneal cavity: method of delineating intraperitoneal fluid distribution. AJR 152: 1205-1210
25. 111In-labeled antibodies. Int J Radiat Appl Instrum Part B 16: 839-845
26. SAS Institute, Cary, NC
27. WinNonlin user guide. Version 1.0 (1995) Statistical Consultants Lexington, Ky
28. Loo JCK, Riegelman S (1968) New method for calculating the intrinsic absorption rate of drugs. J Pharm Sci 57: 918-928